Concerns about safety of Ayurvedic drugs: Do we really mean it?
Sanjeev Rastogi, Ram Harsh Singh.
Abstract
India holds an important position in global pharmaceutical sector. It was valued to the worth of US$ 33 billion in 2017 and is expected to expand at a CAGR of 22.4 per cent over 201520 to reach US$ 55 billion. Indias domestic pharmaceutical market was reported to be of Rs 129,015 crore (US$ 18.12 billion) in 2018 with yearly growth rate of 9.4 %. Indian pharma market mainly composes of bulk drugs, intermediates, drug
formulations,biologicals, Ayurveda , Siddha and Unani (ASU) drugs and surgicals.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
